Docusate Sodium Capsule, Liquid Filled
Product Images NDC 50268-268

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Docusate Sodium (NDC 50268-268). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avpak, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 (Screen Shot 2017 05 17 At 11.10.07 Am)

1 (Screen Shot 2017 05 17 At 11.10.07 Am)
This is a description of a drug called Docusate Sodium, USP that comes in softgel form. It is a stool softener used to relieve occasional constipation and to prevent the formation of dry, hard stools. This product is packaged with 50 softgels (5x10) in unit dose. It is indicated that the product usually produces a bowel movement within 12 to 72 hours. The manufacturer of the product is AvKARE.*
FDA Label Image

2 (Screen Shot 2017 05 17 At 11.10.12 Am)

2 (Screen Shot 2017 05 17 At 11.10.12 Am)
This is a set of instructions and warnings for a drug product. It is advised not to use the product if currently taking certain drugs, experiencing abdominal pain or vomiting, or using it for longer than one week without doctor's directions. If there are sudden changes in bowel movements, medical advice is recommended. The product should not be used for children under 12 years old unless directed by a doctor. The dosage instructions are provided for adults and children over 12, and the product should be taken orally before bedtime for 2-3 days or as directed by a doctor. In case of overdose or ingestion by children, contact medical help or Poison Control Center immediately.*
FDA Label Image

3 (Screen Shot 2017 05 17 At 11.10.19 Am)

3 (Screen Shot 2017 05 17 At 11.10.19 Am)
This is a drug information section, which includes the content of each softgel, storage conditions, identification details, and inactive ingredients. The softgel contains 13mg of Sodium and the storage temperature range is between 15-25°C. The softgel is identified by an imprint, "NVA2." Additionally, it contains several inactive ingredients such as red #40, yellow #6, gelatin, glycerin, and more. The drug is manufactured by AVKARE, Inc at Pulaski, TN with the proprietary formula number 8064 AV and it was last revised on May 2016.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.